This article is more than 5 years old. Information may no longer be current.

Eyenovia posts $5.1 million loss in 2017

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Eyenovia reported a net loss of $2.2 million, or $0.84 per share, in the fourth quarter of 2017 compared with a net loss of $1.2 million, or $0.51 per share, in the fourth quarter of 2016, according to a press release.

Research and development costs increased from $1 million in 2016’s final quarter to $1.7 million in the same time period of 2017, while general and administrative expenses rose from $0.2 million to $0.5 million.

For the full year, the company posted a net loss of $5.1 million, or $2.19 per share, compared with a net loss of $3.5 million, or $1.56 per share, in 2016.

Research and development costs for the year rose 29% to $3.8 million, and general and administrative costs increased 131% from $0.6 million in 2016 to $1.3 million in 2017.

The company had cash totaling $5.2 million as of Dec. 31, 2017.